‘Gratified’ Armstrong in clear
Doping investigation ends without charges
LOS ANGELES— The case against Lance Armstrong is closed. His legacy as a seven-time Tour de France champion endures.
Federal prosecutors dropped their investigation of Armstrong on Friday, ending a nearly two-year effort aimed at determining whether the world’s most famous cyclist and his teammates joined in a doping program during his greatest years.
Armstrong steadfastly has denied he doped during his unparalleled career, but the possibility of criminal charges threatened to stain not only his accomplishments, but his cancer charity work as well. Instead, another attempt to prove a star athlete used performance-enhancing drugs has fallen short, despite years of evidence gathering across two continents.
“I am gratified to learn that the U.S. Attorney’s Office is closing its investigation,” Armstrong said in a statement. “It is the right decision and I commend them for reaching it. I look forward to continuing my life as a father, a competitor, and an advocate in the fight against cancer without this distraction.”
The probe, anchored in Los Angeles where a grand jury was presented evidence by federal prosecutors and heard testimony from Armstrong’s former teammates and associates, began with a separate investigation of Rock Racing.
U.S. Attorney André Birotte Jr. announced in a press release that his office “is closing an investigation into allegations of federal criminal conduct by members and associates of a professional bicycle racing team owned in part by Lance Armstrong.” No reason was given.
The pronouncement comes after a pair of less-than-successful cases against top sports figures accused of doping. Home run king Barry Bonds was found guilty of obstruction of justice and sentenced in December to 30 days’ home detention — a conviction he’s appealing — but prosecutors were unable to convince a jury he lied about using steroids. Roger Clemens’ steroid trial is slated for April 17 after a judge declared a mistrial last summer when prosecutors showed jurors inadmissible evidence.
Investigators looked at whether a doping program was established for Armstrong’s team while, at least part of the time, it received government sponsorship from the U.S. Postal Service. Authorities also examined whether Armstrong encouraged or facilitated doping on the team. He won the Tour de France every year from 1999-2005.
The hurdle for prosecutors wasn’t so much to prove whether any particular cyclist used drugs, but to determine if Armstrong and other team members violated federal conspiracy, fraud or racketeering laws.
Unlike Bonds and Clemens, who testified before a federal grand jury and Congress, respectively, and were accused of lying under oath, Armstrong was not questioned in front of the grand jury.